27
Views
0
CrossRef citations to date
0
Altmetric
CaseReport

Ovarian mucinous cystadenocarcinoma of low malignant potential presented as a paraneoplastic skin lesion

, , , , &
Pages 624-626 | Published online: 02 Jul 2009

References

  • Arnold S M, Patchell Lowy A M, Foon K A. Paraneoplastic syndromes. Cancer: principles and practice of oncology, V T De Vita, Jr, S Hellman, S A Rosenberg. Lippincott Williams & Wilkins, Philadelphia, PA 2001; 2511–2536
  • Ashour A A, Verschraegen C F, Kudelka A P, Kavanagh J J. Paraneoplastic syndromes of gynecologic neoplasms. Journal of Clinical Oncology 1997; 15: 1272–1282
  • Boyd A S, Neldner K H, Menter A. Erythema gyratum repens: a paraneoplastic eruption. Journal of the American Academy of Dermatology 1992; 26: 757–762
  • Herbst A L. Neoplastic diseases of the ovary. Comprehensive gynecology, M A Stenchever, W Droegemueller, A L Herbst, D R Mischell. Mosby, St Louis, MO 2001; 955–998
  • Hovenden A L. Hypertrichosis lanuginosa acquisita associated with malignancy. Clinics in Dermatology 1993; 11: 99–106
  • Kurzrock R, Cohen P R. Erythema gyratum repens. Journal of American Medical Association 1995; 273: 594
  • Lookingbill D P, Spangler N, Sexton F M. Skin involvement as the presenting sign of internal carcinoma: a retrospective study of 7616 cancer patients. Journal of the American Academy of Dermatology 1990; 22: 19–26
  • McKenna K E, Hayes D, McMillan J C. Subacute cutaneous lupus erythematosus-like gyrate erythema and hypertrichosis lanuginosa acquisita associated with uterine adenocarcinoma. British Journal of Dermatology 1992; 127: 443–444
  • Ovarian Tumour Panel of the Royal College of Obstetricians and Gynaecologists. Ovarian epithelial tumors of the borderline malignancy: pathological features and current status. British Journal of Obstetrics and Gynaecology 1983; 90: 743–750
  • Rigel D S, Jacobs M I. Malignant acanthosis nigricans: A review. The Journal of Dermatologic Surgery and Oncology 1980; 6: 923–927
  • Sabir S, James W D, Schuchter L M. Cutaneous manifestations of cancer. Current Opinion in Oncology 1999; 11: 139–144

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.